Cargando…

Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity

Transcription is a dynamic process influenced by the cellular environment: healthy, transformed, and otherwise. Genome-wide mRNA expression profiles reflect the collective impact of pathways modulating cell function under different conditions. In this review we focus on the transcriptional pathways...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waugh, Katherine A., Leach, Sonia M., Slansky, Jill E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586477/ https://www.ncbi.nlm.nih.gov/pubmed/26393659 http://dx.doi.org/10.3390/vaccines3030771

Ejemplares similares

Tolerance of Tumor-Specific T cells in Melanoma Metastases
por: Waugh, Katherine A, et al.
Publicado: (2016)

Mimotope vaccine efficacy gets a "boost" from native tumor antigens
por: Buhrman, Jonathan D., et al.
Publicado: (2013)

CD49b Targeting Inhibits Tumor Growth and Boosts Anti-tumor Immunity
por: Contreras-Kallens, Pamina, et al.
Publicado: (2022)

Group 2 innate lymphoid cells boost CD8(+) T-cell activation in anti-tumor immune responses
por: Wen, Jing, et al.
Publicado: (2023)

Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer
por: Ducoin, Kathleen, et al.
Publicado: (2022)

Low TCR Binding Strength Results in Increased Progenitor-like CD8(+) Tumor-Infiltrating Lymphocytes
por: Hay, Zachary L.Z., et al.
Publicado: (2023)

Targeted Expansion of Tissue-Resident CD8(+) T Cells to Boost Cellular Immunity in the Skin
por: Hobbs, Samuel J., et al.
Publicado: (2019)

In Situ Vaccination with Mitochondria‐Targeting Immunogenic Death Inducer Elicits CD8(+) T Cell‐Dependent Antitumor Immunity to Boost Tumor Immunotherapy
por: Wang, Yuxiang, et al.
Publicado: (2023)

Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer
por: Wei, Pengcheng, et al.
Publicado: (2021)

Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8(+) T Cell Immunity
por: Camp, Faye A., et al.
Publicado: (2022)

Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity
por: Mensali, Nadia, et al.
Publicado: (2019)

Mcl-1 expression influcences CD8+ anti-tumor immunity.
por: Pfannenstiel, Lukas W, et al.
Publicado: (2015)

Natural Splice Variant of MHC Class I Cytoplasmic Tail Enhances Dendritic Cell-Induced CD8(+) T-Cell Responses and Boosts Anti-Tumor Immunity
por: Rodríguez-Cruz, Tania G., et al.
Publicado: (2011)

Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity
por: Hay, Zachary L. Z., et al.
Publicado: (2022)

Dendritic cell subsets require cis-activation for cytotoxic CD8 T cell induction
por: Desch, A. Nicole, et al.
Publicado: (2014)

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity
por: Feng, Qiang, et al.
Publicado: (2022)

Antigen presentation by tumor infiltrating B cells influences CD4 T cell phenotype and function in primary lung cancer patient tumors
por: Bruno, Tullia, et al.
Publicado: (2015)

Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8(+) T cells
por: Matas-Rico, Elisa, et al.
Publicado: (2021)

Zika virus oncolytic activity requires CD8(+) T cells and is boosted by immune checkpoint blockade
por: Nair, Sharmila, et al.
Publicado: (2021)

IL-18: throwing off the shackles to boost anti-tumor immunity
por: Dixon, Karen O., et al.
Publicado: (2020)

Physiological function of phospholipase D2 in anti-tumor immunity: regulation of CD8(+) T lymphocyte proliferation
por: Ngo Thai Bich, Van, et al.
Publicado: (2018)

Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ
por: van den Bijgaart, Renske J. E., et al.
Publicado: (2021)

CTLA-4 blockade boosts the expansion of tumor-reactive CD8(+) tumor-infiltrating lymphocytes in ovarian cancer
por: Friese, Christina, et al.
Publicado: (2020)

Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8+ T cell immune function in acute myeloid leukemia
por: Ren, Jun, et al.
Publicado: (2022)

MAIT cells boost adenovirus-induced CD8(+) T cells
por: Flemming, Alexandra
Publicado: (2021)

Detection of antibody therapy-induced anti-tumor immune responses using anti-CD8 immuno-pet
por: Tavare, Richard, et al.
Publicado: (2015)

The Potential of T Cell Factor 1 in Sustaining CD8(+) T Lymphocyte-Directed Anti-Tumor Immunity
por: Jung, Sungmin, et al.
Publicado: (2021)

Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity
por: Turner, Jacqueline A., et al.
Publicado: (2023)

Cell microparticles loaded with tumor antigen and resiquimod reprogram tumor-associated macrophages and promote stem-like CD8(+) T cells to boost anti-PD-1 therapy
por: Zhang, Xiaoqiong, et al.
Publicado: (2023)

Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
por: Kashyap, Abhishek S., et al.
Publicado: (2019)

Targeting immune checkpoint pathways overcomes tumor-induced CD8+ T cell suppression
por: Pfannenstiel, Lukas W, et al.
Publicado: (2014)

Antigen-Specific T Cells: Analyses of the Needles in the Haystack
por: Slansky, Jill E
Publicado: (2003)

Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8(+ )T cell immunity
por: Bot, Adrian, et al.
Publicado: (2010)

The Anti-Tumor Effect and Mechanism of Triterpenoids in Rhus chinensis Mill. on Reversing Effector CD8+ T-cells Dysfunction by Targeting Glycolysis Pathways in Colorectal Cancer
por: Wang, Gang, et al.
Publicado: (2021)

TIGIT/CD226 Axis Regulates Anti-Tumor Immunity
por: Yeo, Jinah, et al.
Publicado: (2021)

Tumor-Induced CD8+ T-Cell Dysfunction in Lung Cancer Patients
por: Prado-Garcia, Heriberto, et al.
Publicado: (2012)

The transcription factor c-Myb regulates CD8(+) T cell stemness and antitumor immunity
por: Gautam, Sanjivan, et al.
Publicado: (2019)

Probiotics Can Boost the Antitumor Immunity of CD8(+)T Cells in BALB/c Mice and Patients with Colorectal Carcinoma
por: Mao, Jie, et al.
Publicado: (2020)

Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes
por: Sedegah, Martha, et al.
Publicado: (2014)

Targeted suppression of autoreactive CD8(+) T-cell activation using blocking anti-CD8 antibodies
por: Clement, Mathew, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_de75hp89ngsgtf1bp1mma3mecd